Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Use this PAHC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PAHC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PAHC SEC filings page. Lician reads the product cache first so this HTML stays unique to Phibro Animal Health Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full PAHC income, balance, and cash tables.